<div class="docx-content">
<h1 class="text-2xl font-bold mt-8 mb-4">Chlamydia / Chlamydophila species</h1><h2 class="text-xl font-semibold mt-6 mb-3"><strong>1. Taxonomy &amp; Classification</strong></h2><ul><li><strong>Domain</strong>: Bacteria</li><li><strong>Family</strong>: <em>Chlamydiaceae</em></li><li><strong>Genus</strong>: Historically split into <em>Chlamydia</em> and <em>Chlamydophila</em>; recent phylogeny supports single genus <em>Chlamydia</em>, but both names still appear in literature and guidelines.</li><li><strong>Clinically important species</strong>:<ul><li><em>Chlamydia trachomatis</em> – human pathogen only</li><li><em>Chlamydia pneumoniae</em> (formerly <em>Chlamydophila pneumoniae</em>)</li><li><em>Chlamydia psittaci</em> (formerly <em>Chlamydophila psittaci</em>)</li><li><em>Chlamydia abortus</em> – zoonotic, causes ovine/caprine abortion; risk of severe febrile illness with fetal loss in pregnant women</li><li>Rarer: <em>C. felis</em>, <em>C. pecorum</em></li></ul></li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>2. General Microbiology &amp; Laboratory Features</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>A) Morphology &amp; Gram</strong></h3><ul><li>Very small (0.2–1.5 μm), <strong>Gram-negative-like</strong> envelope but no true peptidoglycan layer; cysteine-rich proteins provide structural stability in EB form.</li><li>Obligate intracellular parasites — cannot be grown on artificial media.</li><li>Energy parasites — depend on host ATP.</li><li><strong>Growth: </strong>Require living cells (e.g., McCoy, HeLa, Hep-2) or embryonated eggs.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>D) Staining</strong></h3><ul><li>Gram stain not useful.</li><li><strong>Giemsa</strong>: intracytoplasmic inclusions.</li><li><strong>Immunofluorescence</strong>: genus- or species-specific MOMP antigens.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>E) Antigenic Structure</strong></h3><ul><li><strong>MOMP</strong> (ompA) — species/serovar-specific, used in typing.</li><li>LPS — genus-specific.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>3. Laboratory Diagnosis</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Direct detection</strong></h3><ul><li><strong>NAATs</strong> — first-line for <em>C. trachomatis</em> (urine, vulvovaginal, endocervical, rectal, pharyngeal samples).</li><li><strong>PCR/RT-PCR</strong> for <em>C. pneumoniae</em> and <em>C. psittaci</em> from respiratory or tissue samples.</li><li><strong>Cell culture</strong> — gold standard for legal/forensic confirmation (child sexual abuse).</li><li><strong>Antigen detection</strong> — DFA, EIA; largely replaced by NAATs.<ul><li>DFA staining of EBs in clinical specimens still used for ocular/trachoma field surveys.</li></ul></li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Serology</strong></h3><ul><li><em>C. psittaci</em>: complement fixation test (CFT) still used in UK; microimmunofluorescence (MIF) is gold standard.</li><li><em>C. pneumoniae</em>: MIF is reference; requires paired sera; cross-reactivity with other chlamydiae possible.</li><li><em>C. trachomatis</em>: serology not useful for acute genital infection; IgG ELISA sometimes used in infertility workup.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>5. Antimicrobial Susceptibility</strong></h2><ul><li>No routine AST in clinical labs — requires intracellular culture.</li><li>Naturally resistant to β-lactams (no peptidoglycan in EB form); β-lactams may induce persistence without killing.</li><li>Susceptible to tetracyclines, macrolides, and fluoroquinolones.</li><li>Rare macrolide resistance (23S rRNA mutations) and tetracycline resistance (tet genes) reported.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>6. Biosafety</strong></h2><ul><li><em>C. trachomatis</em>, <em>C. pneumoniae</em> — Hazard Group 2 (BSL-2).</li><li><em>C. psittaci</em> — Hazard Group 3 (BSL-3 containment for culture) due to high aerosol transmissibility.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>7. Clinical Microbiology – Species-Specific</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>A) <em>C. trachomatis</em></strong></h3><ul><li><strong>Biovars/serovars</strong>:<ul><li>Trachoma biovar: A, B, Ba, C → chronic follicular conjunctivitis → blindness.</li><li>Genital biovar:<ul><li>D–K → urogenital infections (NGU, cervicitis, PID, epididymitis, prostatitis, conjunctivitis, neonatal pneumonia).</li><li>L1, L2, L2a, L3 → LGV (invasive STI, proctocolitis, buboes).</li></ul></li></ul></li><li><strong>Complications</strong>: PID, infertility, ectopic pregnancy, chronic pelvic pain, reactive arthritis.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>B) <em>C. pneumoniae</em></strong></h3><ul><li>Human-only pathogen, respiratory transmission.</li><li>Atypical pneumonia, bronchitis, pharyngitis, sinusitis.</li><li>Often mild/subclinical; high adult seroprevalence.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>C) <em>C. psittaci</em></strong></h3><ul><li>Zoonotic (birds: parrots, pigeons, poultry).</li><li><strong>Psittacosis</strong>: atypical pneumonia ± systemic features (fever, headache, hepatosplenomegaly, rash).</li><li>Severe cases: myocarditis, hepatitis, encephalitis.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>D) <em>C. abortus</em></strong></h3><ul><li>Zoonotic from sheep/goats; causes ovine/caprine abortion.</li><li>In pregnant women: severe febrile illness, hepatitis, DIC, high risk of fetal loss.</li><li>Exposure risk: handling birth products.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>8. Treatment</strong></h2><p class="mb-3">C. trachomatis (urogenital): First-line: Doxycycline 100 mg bd × 7 days.LGV: Doxycycline 100 mg bd × 21 days.Trachoma :Azithromycin 20 mg/kg single dose (mass drug administration).C. pneumoniae &amp; C. psittaci: Doxycycline 100 mg bd × 10–14 days; alternatives: macrolides, levofloxacin.C. abortus: Doxycycline; avoid exposure in pregnancy (treatment is largely supportive in severe cases).</p><h2 class="text-xl font-semibold mt-6 mb-3"><strong>9. Prevention &amp; Control</strong></h2><ul><li><em>C. trachomatis</em>: opportunistic NAAT screening in &lt;25s, partner notification/treatment.</li><li><em>C. psittaci</em>: control bird infection, PPE, zoonosis reporting.</li><li><em>C. abortus</em>: PPE, avoid pregnant women handling lambing ewes/goats, veterinary control measures.</li></ul>
</div>